Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-acting versus daily gonadotropin stimulation in poor ovarian responders undergoing IVF
2020-004329-21Phase 4Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- May 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of corifollitropin alfa and follitropin beta in female infertility, poor ovarian response (POR) and anovulatory infertility (2 arms), sponsored by IRCCS Ospedale San Raffaele. Started May 2021; status: completed.
02
Drugs
corifollitropin alfafollitropin beta
03
Conditions
female infertilitypoor ovarian response (POR)anovulatory infertility
Beyond the preview
Go deeper on 2020-004329-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004329-21.